{"id":"W1521568442","doi":"10.1002/ddr.21118","title":"Coagulation Assays in Patients with New Oral Anticoagulants (<scp>NOACs</scp>): Why? When?","year":2013,"lang":"en","type":"article","venue":"Drug Development Research","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Dabigatran; Rivaroxaban; Apixaban; Partial thromboplastin time; Fondaparinux; Pharmacology; Clotting time; Anticoagulant; Thrombin time; Prothrombin time; Medicine; Coagulation testing; Thromboplastin; Drug; Coagulation; Discovery and development of direct thrombin inhibitors; Direct thrombin inhibitor; Chemistry; Thrombin; Internal medicine; Warfarin; Thrombosis; Platelet; Atrial fibrillation; Venous thromboembolism","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001930523,0.0003413637,0.0008170179,0.0009398879,0.0002912292,0.001909237,0.0003173699,0.001294711,0.002737801],"category_scores_gemma":[0.005218125,0.0001253503,0.0004136953,0.001302913,0.0005132728,0.001031387,0.000205399,0.001265507,0.001166735],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004998549,"about_ca_system_score_gemma":0.0004978855,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009454124,"about_ca_topic_score_gemma":0.0008631385,"domain_scores_codex":[0.9988058,0.0004231922,0.0002487121,0.0001283196,0.0003080445,0.00008594999],"domain_scores_gemma":[0.9964274,0.001132998,0.001085944,0.0001079698,0.0009759518,0.0002698442],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002307574,0.0004693511,0.5720933,0.002323748,0.0002689062,0.001667889,0.0003824709,0.0001637936,0.002614422,0.001797892,0.04236356,0.3735471],"study_design_scores_gemma":[0.0005946725,0.003354334,0.7798072,0.009299733,0.001471183,0.02264404,0.003399601,0.002093738,0.009548816,0.008872606,0.158707,0.0002071477],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"commentary","genre_scores_codex":[0.3398312,0.5304961,0.006112983,0.08181196,0.004336107,0.0002307841,0.001467495,0.0002559421,0.03545753],"genre_scores_gemma":[0.8958822,0.07706228,0.004872352,0.01169156,0.004673772,0.0001449345,0.000683437,0.00003963157,0.004949862],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.002737801,"threshold_uncertainty_score":0.01020968,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1032542157200367,"score_gpt":0.3556670945648224,"score_spread":0.2524128788447856,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}